GWPH GW Pharmaceuticals PLC ADRs

GW Pharmaceuticals PLC is engaged in the research, development and commercialisation of cannabinoid prescription medicines using botanical extracts derived from the Cannabis Sativa plant. This is an ADR of a company that does not have its stock publicly traded anywhere else in the world.

$214.91  +0.74 (0.35%)
As of 03/05/2021 15:59:48 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
ADRs
Mid cap
Health Care
Drug Manufacturers—General
United Kingdom
United Kingdom
05/01/2013
30,913,178
1,164,101
$6,644,478,479
0.00%
SEC Edgar Online
10-Q
10-K
36197T103
US36197T1034
B94RPL5

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-114.31
9.07
12.60
-7.84%
-11.03%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy